It is a pharma private limited company based in Ahmedabad, Gujarat, India, established in 2010.
2010 | Ahmedabad, Gujarat, India | ActiveRainvis Pharmaceuticals Private Limited, a active private limited company, was established on 06 July 2010 in Ahmedabad, Gujarat, India. Engaging in pharmaceutical retailers & distributors within the trade sector, it holds CIN: U24239GJ2010PTC061454. Registered under ROC Roc Ahmedabad. it is unlisted. It has an authorized capital of ₹1.50 M and a paid-up capital of ₹1.50 M.
It upholds a compliant status. Its leadership includes Ranjit Kumar Parija (Director), Parul Ranjit Rautray (Director). Past directors included Ranjit Bankanidhi Rautray, Ranjit Kumar Parija, Sandhyarani Nayak. It holds ₹2.50 M open charges and no settled loans. Its latest AGM occurred on 30 September 2019, with the balance sheet filed on 31 March 2019. It is based at 3 Dg, Niddhishri Co. Op. H. Soc. Ltd Opp. Visat Petrol Pump, Gandhinagar High, Way, Ahmedabad, Gujarat, 380005.
U24239GJ2010PTC061454
061454
06 July 2010
₹1.50 M
₹1.50 M
Roc Ahmedabad
Unlisted
Active
Explore comprehensive insights into Rainvis Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Ranjit Kumar Parija | Director | 22 Jan 2019 | Current |
| Parul Ranjit Rautray | Director | 23 Feb 2017 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 22 Jan 2019 | Past |
| Pramod Abcsdd | Additional Director | 30 Sep 2019 | Past |
| Pramod Abcsdd | Director | 23 Feb 2017 | Past |
| Pramod Abcsdd | Director | 06 Sep 2010 | Past |
| Pramod Abcsdd | Director | 23 Feb 2017 | Past |
| Pramod Abcsdd | Additional Director | 29 Sep 2017 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Rainvis Pharmaceuticals Private Limited, for the financial year ended 2019, experienced Minor drop in revenue, with a 3.8% decrease. The company also saw a substantial improvement in profitability, with a 64.83% increase in profit. The company's net worth observed a substantial decline by a decrease of 49.21%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2019, Rainvis Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹2,500,000.00
₹0
| Date | Lender | Amount | Status |
|---|---|---|---|
| 28 Dec 2017 | Others | ₹2.50 M | Open |
Explore comprehensive loan charge details -
Unlock and access historical data on people associated with Rainvis Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Rainvis Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Rainvis Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Rainvis Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2019 as per latest MCA records. was recorded as a recent event.
Progress on Rainvis Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2019 with Roc Ahmedabad. was documented.
Progress on Ranjit Kumar Parija was appointed as a Director was appointed as a Director on 22 Jan 2019 & has been associated with this company since 6 years 10 months . was documented.
The activity A charge with Others amounted to Rs. 2.50 M with Charge ID 100163119 was registered on 28 Dec 2017. was completed.
Progress on Parul Ranjit Rautray was appointed as a Director was appointed as a Director on 23 Feb 2017 & has been associated with this company since 8 years 9 months . was documented.
Progress on Rainvis Pharmaceuticals Private Limited was registered on 06 Jul 2010 with Roc Ahmedabad & aged 15 years 4 months as per MCA records. was documented.
The CIN of Rainvis Pharmaceuticals Private Limited is U24239GJ2010PTC061454.
Rainvis Pharmaceuticals Private Limited is headquartered at 3 Dg, Niddhishri Co. Op. H. Soc. Ltd Opp. Visat Petrol Pump, Gandhinagar High, Way, Ahmedabad, Gujarat, 380005.
Rainvis Pharmaceuticals Private Limited was incorporated on 06 July 2010.
The current directors of Rainvis Pharmaceuticals Private Limited are
The primary industry of Rainvis Pharmaceuticals Private Limited is Trade.
Rainvis Pharmaceuticals Private Limited is unlisted.
The authorized capital of Rainvis Pharmaceuticals Private Limited is ₹1.50 M, and the paid-up capital is ₹1.50 M.
The compliance status of Rainvis Pharmaceuticals Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX